Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07534709 · ClinicalTrials.gov registry record · Phase 4
Suzetrigine for Opioid-Free Recovery After Cesarean Delivery
A Phase 4 study, sponsored by University of Texas at Austin.
- Not yet
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT07534709 is a Phase 4 study that has not yet begun recruiting, run by University of Texas at Austin. The registered enrollment target is 90 participants.
The verdict
NCT07534709, a Phase 4 study, has not yet begun recruiting, sponsored by University of Texas at Austin.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine whether suzetrigine increases the proportion of patients who remain completely opioid-free from completion of surgery through 72 hours after cesarean delivery. The main question it aims to answer is: Does adjunctive suzetrigine, when added to a standardized multimodal postoperative analgesic regimen, increase the proportion of patients who remain opioid-free during the first 72 hours after cesarean delivery? Researchers will compare suzetrigine to a placebo (a look-alike substance that contains no drug) to evaluate this outcome. Participants will: * Receive either suzetrigine or placebo after cesarean delivery * Receive standard postoperative pain management, including acetaminophen, nonsteroidal anti-inflammatory drugs, and neuraxial morphine * Have opioid medications available as needed for breakthrough pain * Be followed during hospitalization and after discharge to assess pain, recovery, and medication use
Interventions
- DRUG Placebo
- DRUG Suzetrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07534709
The ClinicalTrials.gov registry entry for NCT07534709 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07534709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07534709 about?
NCT07534709 is a clinical study titled "Suzetrigine for Opioid-Free Recovery After Cesarean Delivery". The goal of this clinical trial is to determine whether suzetrigine increases the proportion of patients who remain completely opioid-free from completion of surgery through 72 hours after cesarean delivery. The main question it aims to answer is: Does adjunctive suzetrigine, when added to a stand...
What is the current status of trial NCT07534709?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2026-06. Estimated completion is 2028-05.
What interventions are being tested in trial NCT07534709?
The interventions under investigation include: Placebo (DRUG), Suzetrigine (DRUG).
Who is sponsoring clinical trial NCT07534709?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.